BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24187755)

  • 21. Stem-cell agency faces budget dilemma.
    Hayden EC
    Nature; 2012 Jan; 482(7383):15. PubMed ID: 22297945
    [No Abstract]   [Full Text] [Related]  

  • 22. 2010 World Stem Cell Summit--part 1. October 4-6, 2010, Detroit, MI, USA.
    Vertès A
    IDrugs; 2010 Dec; 13(12):819-21. PubMed ID: 21154132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regenerative nanomedicines: an emerging investment prospective?
    Prescott C
    J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S783-7. PubMed ID: 20826478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New era of regenerative medicine for cardiovascular diseases.
    Tse HF
    Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
    [No Abstract]   [Full Text] [Related]  

  • 26. Promises and challenges of stem cell research for regenerative medicine.
    Power C; Rasko JE
    Ann Intern Med; 2011 Nov; 155(10):706-13, W217. PubMed ID: 22084335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
    Johnson S
    Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
    [No Abstract]   [Full Text] [Related]  

  • 28. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. California's vote to revive controversial stem-cell institute sparks debate.
    Subbaraman N
    Nature; 2020 Nov; 587(7835):535. PubMed ID: 33199902
    [No Abstract]   [Full Text] [Related]  

  • 30. Global update: Scotland.
    Courtney A
    Regen Med; 2011 Nov; 6(6 Suppl):150-2. PubMed ID: 21999279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lancet Commission: Stem cells and regenerative medicine.
    Cossu G; Birchall M; Brown T; De Coppi P; Culme-Seymour E; Gibbon S; Hitchcock J; Mason C; Montgomery J; Morris S; Muntoni F; Napier D; Owji N; Prasad A; Round J; Saprai P; Stilgoe J; Thrasher A; Wilson J
    Lancet; 2018 Mar; 391(10123):883-910. PubMed ID: 28987452
    [No Abstract]   [Full Text] [Related]  

  • 32. Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions 1-31 March 2017.
    Ilic D; Berengueras JM
    Regen Med; 2017 Jul; 12(5):479-486. PubMed ID: 28722542
    [No Abstract]   [Full Text] [Related]  

  • 33. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frontline in the research of regenerative medicine].
    Inoue H; Okano H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):886. PubMed ID: 21921489
    [No Abstract]   [Full Text] [Related]  

  • 35. Research status and prospect of stem cells in the treatment of diabetes mellitus.
    Liu X; Wang Y; Li Y; Pei X
    Sci China Life Sci; 2013 Apr; 56(4):306-12. PubMed ID: 23564185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in stem cells and regenerative medicine].
    Wang L; Zhu H; Hao J; Zhou Q
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):871-9. PubMed ID: 26672363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the stem cell and regenerative medicine industry.
    Ilic D
    Regen Med; 2012 Sep; 7(5):645-8. PubMed ID: 22954435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalyzing stem cell research.
    Willemse L; Lyall D; Rudnicki M
    Regen Med; 2008 Sep; 3(5):761-4. PubMed ID: 18729799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell fate plug and play: direct reprogramming and induced pluripotency.
    Chambers SM; Studer L
    Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.